source
- Viking touts once-a-month weight loss maintenance dataViking Therapeutics says patients who switched to a once-a-month dosing regimen of its obesity drug did not regain much weight after 12 weeks, bolstering the potential of a less frequent schedule.…
- Anaconda Biomed snares $56M in funding for endovascular techMedtech startup Anaconda Biomed has hauled in $53 million to help finish off work on a pivotal trial for its endovascular project.